These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 7542859

  • 1. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
    Sciarra F.
    Ann N Y Acad Sci; 1995 Jun 12; 761():66-78. PubMed ID: 7542859
    [Abstract] [Full Text] [Related]

  • 2. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S, Di Silverio F, Iraci R, Martini C, Lanzara S, Falasca P, Poggi M, Stigliano A, Sciarra F, Toscano V.
    J Clin Endocrinol Metab; 2001 Apr 12; 86(4):1700-6. PubMed ID: 11297606
    [Abstract] [Full Text] [Related]

  • 3. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
    Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, Lanzara S, Silverio FD.
    J Androl; 1997 Apr 12; 18(5):488-94. PubMed ID: 9349746
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia.
    Lubrano C, Petrangeli E, Catizone A, Santonati A, Concolino G, Rombolá N, Frati L, Di Silverio F, Sciarra F.
    J Steroid Biochem; 1989 Apr 12; 34(1-6):499-504. PubMed ID: 2483222
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
    Yang Y, Chisholm GD, Habib FK.
    Br J Cancer; 1993 Jan 12; 67(1):152-5. PubMed ID: 7678977
    [Abstract] [Full Text] [Related]

  • 6. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J, Hicks LL, Walsh PC.
    J Clin Invest; 1980 May 12; 65(5):1051-9. PubMed ID: 6154062
    [Abstract] [Full Text] [Related]

  • 7. Benign prostatic hyperplasia--video image analysis and its relationship to androgen and epidermal growth factor receptor expression.
    Frydenberg M, Foo TM, Jones AS, Grace J, Hensley WJ, Rogers J, Pearson BS, Raghavan D.
    J Urol; 1991 Sep 12; 146(3):872-6. PubMed ID: 1714972
    [Abstract] [Full Text] [Related]

  • 8. Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
    de Jong FH, Reuvers PJ, Bolt-de Vries J, Mulder E, Blom JH, Schroeder FH.
    J Steroid Biochem Mol Biol; 1992 Mar 12; 42(1):49-55. PubMed ID: 1373073
    [Abstract] [Full Text] [Related]

  • 9. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB.
    Cancer Res; 1995 Jul 15; 55(14):3197-203. PubMed ID: 7606741
    [Abstract] [Full Text] [Related]

  • 10. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R, Puah CM.
    J Endocrinol; 1981 Feb 15; 88(2):255-62. PubMed ID: 6162906
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I, Schelling KH, Adams JY, Merk FB, Alroy J.
    Prostate; 2001 May 15; 47(3):149-63. PubMed ID: 11351344
    [Abstract] [Full Text] [Related]

  • 15. Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia.
    Lubrano C, Toscano V, Petrangeli E, Spera G, Trotta MC, Rombolà N, Frati L, Di Silverio F, Sciarra F.
    J Steroid Biochem Mol Biol; 1993 Oct 15; 46(4):463-8. PubMed ID: 7692939
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
    Krieg M, Bartsch W, Janssen W, Voigt KD.
    J Steroid Biochem; 1979 Jul 15; 11(1B):615-24. PubMed ID: 90754
    [No Abstract] [Full Text] [Related]

  • 19. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B, Mayer D.
    Int J Oncol; 2008 Sep 15; 33(3):623-9. PubMed ID: 18695894
    [Abstract] [Full Text] [Related]

  • 20. Subnormal tissue 3 alpha-androstanediol and androsterone in prostatic hyperplasia.
    Meikle AW, Stringham JD, Olsen DC.
    J Clin Endocrinol Metab; 1978 Oct 15; 47(4):909-13. PubMed ID: 95628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.